Barry N. Silberg, M.D., F.A.C.S. has been in practice in Santa Rosa, CA, since 1979 and has served several terms as Chief of Plastic Surgery at Santa Rosa Memorial Hospital. In addition to his busy cosmetic surgery practice, Dr. Silberg is a member of the Level II Trauma Team at Santa Rosa Memorial Hospital, where he performs major reconstructive surgery on patients who have incurred traumatic and complex injuries to the face and body.
Dr. Barry Silberg is a specialist in Cosmetic, Plastic, and Reconstructive Surgery and is certified by the American Board of Plastic Surgery. The American Board of Plastic Surgery is the ONLY organization representing exclusively Plastic Surgeons. This Board requires extensive training in General Surgery and completion of a full university residency-training program in Plastic Surgery. Certification with the American Board of Plastic Surgery indicates that the surgeon has passed challenging written and oral examinations demonstrating in-depth knowledge of the specialty. The American Board of Plastic Surgery is the only Board recognized by the American Board of Medical Specialties for the certification of Plastic Surgeons.
Dr. Silberg is also a member of the American Society for Aesthetic Plastic Surgery (ASAPS), an organization devoted exclusively to advancing the science and art of cosmetic plastic surgery. Its members are a select group of board-certified plastic surgeons who have reached the highest achievement in cosmetic plastic surgery. In addition, Dr. Silberg is a Fellow of the American College of Surgeons. This is a title that is granted by peer surgeons only after a careful evaluation of the candidate’s training, background and professional standing. To maintain membership, a Plastic Surgeon must show evidence of continued education and excellence in the specialty.
Dr. Silberg has performed thousands of cosmetic surgeries incorporating leading edge technologies and state-of-the-art techniques and he has been a lecturer and teacher for cosmetic surgeons worldwide, having taught throughout the U.S., France, South America, and Asia. Dr. Silberg has also volunteered with Rotoplast in the Philippines performing cleft lip surgery on dozens of children.
Dr. Silberg has served several terms as Chief of Plastic Surgery at Santa Rosa Memorial Hospital. As a service to the local community, Dr. Silberg serves as a member of the Level II Trauma Team at Santa Rosa Memorial Hospital treating patients who have sustained serious and complex injuries as the result of an accident.
Local pediatrician, Dr. David Smith, told NorthBayBiz.com that Dr. Silberg is rare among plastic surgeons: “Many are quick to boast of their trips to Africa to mend cleft palates, but when you have a kid who’s been facially disfigured by a dog bite, they can’t seem to make it to the hospital here. I know Dr. Silberg has done the foreign trips, too, but he’s also quick to show up when there’s a serious problem locally. He’s not one of those who’ve gone over to ‘the green side.” (NorthBayBiz.com)
Dr. Silberg attended Texas A&M University after which he attended The University of Texas Southwestern Medical School, Dallas, Texas, where he graduated with a Doctor of Medicine degree. His internship was at the University of Wisconsin the following year. For the next three years, Dr. Silberg was a Major in the United States Army Medical Corps serving in Germany. He was awarded the Army Commendation Medal for Meritorious Service for his contributions to NATO exercises throughout Europe.
Following service, Dr. Silberg trained in General Surgery at the Baylor College of Medicine, Houston, Texas under the highly respected heart and vascular surgeon, Dr. Michael E. DeBakey. During that time, he studied Plastic Surgery with Dr. Thomas Cronin, the inventor of the modern breast implant. He completed further training in Plastic Surgery at the University of Mississippi after which he became the first Chief Resident in Plastic Surgery at the University of California, Davis. After completing his training, he continued as Clinical Instructor in Plastic Surgery.
Dr. Silberg invented the Silberg Tissue Preparation System, which was FDA cleared in 2003 and which is now used worldwide. The technique makes surgery and liposuction less traumatic by super-hydrating the tissue, which makes it looser and prevents exposure dehydration. This results in a better overall result, faster recovery, less bruising and discomfort, and lower risk of postoperative complications. In addition to its use in plastic surgery, the Silberg Tissue Preparation System is being used in a current FDA and IRB approved clinical study at Sonoma West Medical Center for a new way of delivering antibiotics directly to the target tissue.
Dr. Silberg is the founder of the Santa Rosa Antibiotic Effectiveness Project, Inc., a 501(c)(3) organization that has been formed to advance the science of drug delivery. He is also the founder of Sonescence, Inc., which is currently conducting an FDA and IRB approved clinical study at Sonoma West Medical Center. See articles about Dr. Silberg at NorthBay Biz, North Bay Business Journal, and Pacific Health Magazine.
Dr. Silberg has five issued patents, three published patents applications, and three pending patent applications.
Dr. Silberg attends several Plastic Surgery meetings each year and makes presentations to other Plastic Surgeons on new developments in Plastic Surgery and medicine. He has published numerous articles and has presented his work as an invited guest professor and/or surgeon in Japan, Thailand, France, Mexico, Korea, and Brazil as well as at major medical meetings in the United States. He is the inventor of External Ultrasound Assist, used worldwide to make surgery less traumatic. His instrument, the Silberg Graft Passer, is widely used in soft tissue augmentation of the face, making procedures more accurate. In October, 2015, Dr. Silberg was a guest speaker at Beijing’s Institute of Technology 5th Annual Symposium of Drug Delivery System in Beijing, China. In December, 2015, Dr. Silberg was a guest speaker and the NYU School of Medicine and the Bronx VA in New York to present a new drug delivery method.